
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DIC CRISPR/Cas9 KO Plasmid (h) | sc-417651 | 20 µg | $397.00 |
SLC25A10 encodes the mitochondrial dicarboxylate carrier (DIC), an inner membrane transporter that exchanges malate and succinate with inorganic phosphate, linking mitochondrial metabolite flux to cytosolic biosynthetic and redox demands. By regulating the availability of dicarboxylates, DIC influences anaplerosis, gluconeogenic and lipogenic precursor balance, and coordination of the TCA cycle with oxidative phosphorylation. Altered SLC25A10 activity has been associated with metabolic reprogramming and mitochondrial stress responses, making it relevant for studying pathways that couple nutrient utilization to mitochondrial function. As a mitochondrial carrier family member, DIC also provides a handle to interrogate how transport constraints shape ROS handling and proliferative metabolism in disease-relevant cell models.
DIC CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC25A10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC25A10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC25A10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish DIC protein expression.
This CRISPR knockout system enables efficient generation of SLC25A10-deficient cell models for investigation of DIC signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.